​

DarioHealth (DRIO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DRIO Stock Forecast

DarioHealth (DRIO) stock forecast, based on 3 Wall Street analysts, predicts a 12-month average price target of $10.75, with a high of $14.00 and a low of $7.50. This represents a 1528.79% increase from the last price of $0.66.

- $3 $6 $9 $12 $15 High: $14 Avg: $10.75 Low: $7.5 Last Closed Price: $0.66

DRIO Stock Rating

DarioHealth stock's rating consensus is Buy, based on 3 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 3 0 3 Strong Sell Sell Hold Buy Strong Buy

DRIO Forecast vs Benchmarks

TypeNameUpside
StockDarioHealth1528.79%
SectorHealthcare Stocks 25.20%
IndustryDiagnostics & Research Stocks16.01%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.66$0.66$0.66
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25-31--4
Dec, 24-3---3
Nov, 24-3---3
Oct, 2413---4
Sep, 2412---3
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 16, 2022Industrial Alliance Securities$7.50$5.1844.79%1036.36%
Aug 18, 2022Cowen & Co.$14.00$5.49155.01%2021.21%
May 16, 2022Cowen & Co.$18.00$6.33184.36%2627.27%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Jun 14, 2024Cowen & Co.BuyBuyhold
Nov 16, 2022Alliance Global PartnersBuyBuyhold
Aug 18, 2022Aegis CapitalBuyBuyhold
Aug 18, 2022Cowen & Co.OutperformOutperformhold
May 16, 2022Aegis CapitalBuyBuyhold
May 16, 2022Cowen & Co.OutperformOutperformhold
May 13, 2022Alliance Global PartnersBuyupgrade

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-4.86$-4.63$-2.63$-1.93----
Avg Forecast$-5.13$-4.72$-2.93$-1.54$-1.12$-1.01$-0.86$-0.63
High Forecast$-5.31$-4.89$-3.00$-1.64$-1.20$-1.08$-1.11$-0.67
Low Forecast$-4.97$-4.57$-2.83$-1.46$-1.07$-0.96$-0.60$-0.60
Surprise %-5.26%-1.91%-10.24%25.32%----

Revenue Forecast

$5M $14M $23M $32M $41M $50M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$7.58M$20.51M$27.66M$20.35M----
Avg Forecast$7.60M$20.61M$27.59M$20.50M$26.81M$35.63M$41.35M$47.14M
High Forecast$7.42M$20.12M$26.84M$19.73M$25.80M$34.29M$39.79M$45.36M
Low Forecast$7.82M$21.19M$28.09M$21.54M$28.16M$37.43M$43.44M$49.52M
Surprise %-0.37%-0.49%0.23%-0.75%----

Net Income Forecast

$-200M $-160M $-120M $-80M $-40M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-28.99M$-76.76M$-62.19M$-54.86M----
Avg Forecast$-145.41M$-133.88M$-83.24M$-44.05M$-32.30M$-28.99M$-24.26M$-18.02M
High Forecast$-150.69M$-138.74M$-85.20M$-46.56M$-33.96M$-30.64M$-31.61M$-19.05M
Low Forecast$-140.92M$-129.74M$-80.31M$-41.55M$-30.31M$-27.34M$-16.90M$-17.00M
Surprise %-80.06%-42.66%-25.29%24.53%----

DRIO Forecast FAQ

Is DarioHealth stock a buy?

DarioHealth stock has a consensus rating of Buy, based on 3 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that DarioHealth is a favorable investment for most analysts.

What is DarioHealth's price target?

DarioHealth's price target, set by 3 Wall Street analysts, averages $10.75 over the next 12 months. The price target range spans from $7.5 at the low end to $14 at the high end, suggesting a potential 1528.79% change from the previous close price of $0.66.

How does DarioHealth stock forecast compare to the average forecast of its sector, industry, and investment themes?

DarioHealth stock forecast shows a 1528.79% upside, outperforming the average forecast for the healthcare stocks sector (25.20%) and outperforming the diagnostics & research stocks industry (16.01%).

What is the breakdown of analyst ratings for DarioHealth over the past three months?

  • January 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is DarioHealth’s EPS forecast?

DarioHealth's average annual EPS forecast for its fiscal year ending in December is -1.12 for 2024, a -41.97% decrease from the reported $-1.93 in 2023. The prediction for 2025 is $-1.01, $-0.86 for 2026, and $-0.63 for 2027.

What is DarioHealth’s revenue forecast?

DarioHealth's average annual revenue forecast for its fiscal year ending in December is $26.81M for 2024, a 31.73% increase from the reported $20.35M in 2023. The forecast for 2025 is $35.63M, $41.35M for 2026, and $47.14M for 2027.

What is DarioHealth’s net income forecast?

For its fiscal year ending in December, DarioHealth's average annual net income forecast is $-32.299M for 2024, reflecting a -41.13% decrease from the reported $-54.86M in 2023. The projection for 2025 is $-28.988M, $-24.258M for 2026, and $-18.022M for 2027.